Opportunity Information: Apply for RFA CA 21 060

The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) is a National Cancer Institute (NCI) grant program meant to help exceptional postdoctoral researchers move more quickly from mentored training into fully independent faculty careers. The core goal is to strengthen the pipeline of NCI-supported investigators by supporting a focused mentored phase followed by a transition into an independent, tenure-track (or equivalent) position, with NCI support continuing across that transition so awardees can establish a competitive research program. It is specifically aimed at postdoctoral fellows who already have strong doctoral preparation (research and/or clinical doctoral degrees) and do not need a long additional period of mentored training beyond what they have already completed.

A central feature of this opportunity is the emphasis on a timely shift to independence. The K99 portion supports the candidate while they are still in a mentored postdoctoral role, helping them build the final set of skills, preliminary data, and productivity needed to compete for an independent faculty appointment. The R00 portion then provides support once the candidate secures an independent faculty position, giving them protected time and research funding to launch their lab or independent research direction and position themselves for future major NIH/NCI awards. NCI notes particular encouragement for applicants working in data science and cancer control science, signaling strong programmatic interest in research that improves cancer outcomes through analytics, computation, population-based approaches, implementation, prevention, survivorship, and related areas.

This specific FOA (RFA-CA-21-060) is the version that does not allow the applicant to lead an independent clinical trial. In practical terms, the proposed research plan cannot involve the applicant serving as the lead investigator for an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. At the same time, the FOA does allow candidates to gain clinical trial experience as part of their training as long as the trial is led by a mentor or co-mentor. Applicants who do intend to lead a clinical trial or lead an ancillary clinical trial are directed to use the companion announcements (RFA-CA-21-061 or RFA-CA-21-062), which are structured for that purpose.

Eligibility for applying as an institution is broad and includes many common U.S. organizational types such as public and private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (other than small businesses), small businesses, and a range of government entities (state, county, city/township, special district governments), as well as independent school districts and public housing authorities/Indian housing authorities. It also includes Native American tribal governments (federally recognized) and other tribal organizations, and it explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

Foreign participation rules are more restrictive. Non-domestic (non-U.S.) entities and non-U.S. institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components may be permitted under NIH policy (as defined in the NIH Grants Policy Statement), meaning parts of the work can potentially involve an allowable foreign component even though a foreign institution cannot be the primary applicant.

From the opportunity metadata, this is an NIH discretionary grant mechanism under CFDA 93.398, with the FOA posted by NIH/NCI. The funding opportunity number is RFA-CA-21-060, and the original closing date listed in the source information was 2022-02-28. The program description does not provide an award ceiling or expected number of awards in the supplied text, but the intent is clear: to provide structured support that helps outstanding early stage postdoctoral researchers transition into stable, independent cancer research careers without requiring them to lead a clinical trial as part of the application.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
  • This funding opportunity was created on 2021-11-03.
  • Applicants must submit their applications by 2022-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 21 060

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: FY 2022 Cooperative Endangered Species Conservation Fund (CESCF) Traditional Conservation Grants Program (Service Legacy Region 7)

Previous opportunity: Early Career Research Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 21 060

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 21 060) also looked into and applied for these:

Funding Opportunity
NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) Apply for RFA DA 22 036

Funding Number: RFA DA 22 036
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) Apply for PAR 22 032

Funding Number: PAR 22 032
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Apply for PAR 22 071

Funding Number: PAR 22 071
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $475,000
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 22 001

Funding Number: RFA CA 22 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 22 002

Funding Number: RFA CA 22 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) Apply for PAR 22 031

Funding Number: PAR 22 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional) Apply for PAR 21 358

Funding Number: PAR 21 358
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) Apply for RFA DA 22 044

Funding Number: RFA DA 22 044
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed) Apply for RFA DA 22 045

Funding Number: RFA DA 22 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Pilot and Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional) Apply for RFA DA 22 048

Funding Number: RFA DA 22 048
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional) Apply for RFA DA 22 047

Funding Number: RFA DA 22 047
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional) Apply for RFA DA 22 043

Funding Number: RFA DA 22 043
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional) Apply for RFA DA 22 046

Funding Number: RFA DA 22 046
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional) Apply for RFA DA 22 042

Funding Number: RFA DA 22 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional) Apply for RFA DA 22 034

Funding Number: RFA DA 22 034
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional) Apply for RFA DA 22 051

Funding Number: RFA DA 22 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional) Apply for RFA DA 22 049

Funding Number: RFA DA 22 049
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) Apply for RFA MH 22 170

Funding Number: RFA MH 22 170
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 22 008

Funding Number: RFA CA 22 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 22 007

Funding Number: RFA CA 22 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 21 060", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: